Cariprazine

Major

Cariprazine Duvelisib Copiktra Explained Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure Details Cariprazine Echinacea Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Efavirenz Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Elafibranor Iqirvo Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Elagolix Orilissa Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Enasidenib Idhifa Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Enzalutamide Xtandi Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Erythromycin Erythrocin Stearate Explained Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure Details Cariprazine Eslicarbazepine Acetate Aptiom Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Etravirine Intelence Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Fedratinib Inrebic Explained Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure Details Cariprazine Fluconazole Diflucan Explained Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure Details Cariprazine Fosamprenavir Lexiva Explained Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure Details Cariprazine Fosnetupitant Explained Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure Details Cariprazine Fosphenytoin Cerebyx Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Garlic Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Ginkgo Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Ginseng Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Idelalisib Zydelig Explained Increased exposure to cariprazine and its active metabolite, didesmethylcariprazine Details Cariprazine Imatinib Gleevec Explained Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure Details Cariprazine Indinavir Explained Increased exposure to cariprazine and its active metabolite, didesmethylcariprazine Details Cariprazine Insulin Aspart, Recombinant Fiasp Explained Reduced blood glucose lowering effect of insulin Details Cariprazine Insulin Glargine, Recombinant Basaglar Explained An increased risk of hypoglycemia Details Cariprazine Insulin Icodec-Abae Awiqli Explained Reduced efficacy of insulin icodec-abae Details Cariprazine Isavuconazole Explained Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure Details Cariprazine Isavuconazonium Cresemba Explained Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure Details Cariprazine Itraconazole Sporanox Explained Increased exposure to cariprazine and its active metabolite, didesmethylcariprazine Details Cariprazine Ivosidenib Tibsovo Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Ketoconazole Extina Explained Increased exposure to cariprazine and its active metabolite, didesmethylcariprazine Details Cariprazine Lefamulin Xenleta Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure Details Cariprazine Lenacapavir Sunlenca Explained Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure Details Cariprazine Lesinurad Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Letermovir Prevymis Explained Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure Details Cariprazine Lonafarnib Zokinvy Explained Increased exposure to cariprazine and its active metabolite, didesmethylcariprazine Details Cariprazine Lopinavir Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Lorlatinib Lorbrena Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Lumacaftor Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Methadone Diskets Explained Increased risk of respiratory and CNS depression Details Cariprazine Methylprednisolone Depo-Medrol Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Mifepristone Korlym Explained Increased exposure to cariprazine and its active metabolite, didesmethylcariprazine Details